The opportunity to be part of an entrepreneurial team which adds value across the full spectrum of UK mid-market opportunities is compelling.
Andrew is an Investment Director with responsibility for appraising and executing majority and minority as well as originating new mid-market opportunities, with a focus on the healthcare sector. Andrew was involved in our investments in O'Neill Patient and Medivet and has a focus on healthcare and life sciences.
Prior to joining Inflexion in 2016, Andrew was an Investment Director at Octopus Healthcare. Andrew was involved in creating a new entrant to the UK private hospital market, in addition to the acquisitive build-up of a new operator in the UK special educational needs sector. Prior to Octopus, Andrew spent four years at GI Partners where he supported the growth, merger and eventual IPO of three healthcare platforms. Andrew began his career at PwC and was also an Analyst at Three Delta LLP.
Andrew has a first-class MEng in Mechanical Engineering from Sheffield University. Outside of work, what Andrew lacks in talent he makes up with enthusiasm in the fields of mountain biking, snowboarding and rock climbing. His wife and children may say that the same applies to his cooking!